← SynDRA
CARMOTEROL
SynDRA canonical compound SYN0021959 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ADRB2 |
|---|
| Mechanism of action | adrenergic receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- ADRB2 AGONIST
- Beta-2 adrenergic receptor agonist
- adrenergic receptor agonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- CHF-4226
- Quinoterol
- TA-2005
- 8-Hydroxy-5-((R)-1-hydroxy-2-(((R)-1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)quinolin-2(1H)-one
- UNII-9810NUL4D1
- CHEMBL1094785
- 9810NUL4D1
- 2(1h)-quinolinone, 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-
- 8-hydroxy-5-[(1R)-1-hydroxy-2-{[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]-1,2-dihydroquinolin-2-one
- Carmoterol [INN]
- 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]-1H-quinolin-2-one
- AC1Q6MT1
- Carmoterol hydrochloride
- CHF 4226.01
- 8-Hydroxy-5-((1R)-1-hydroxy-2-(N-(1R)-2-(p-methoxyphenyl)isopropylamino)ethyl)carbostyril HCl
- 8-Hydroxy-5-(1-hydroxy-2-(N-(2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)carbostyril hydrochloride
- 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]-1H-quinolin-2-one hydrochloride
- 8-hydroxy-5-[(1r)-1-hydroxy-2-{[(2r)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]quinolin-2(1h)-one hydrochloride(1:1)
- RefChem:1099361
- Carmoterol HCl
- 0WLO9P0V75
- CHF-4226.01
- UNII-0WLO9P0V75
- Carmoterolhydrochloride
- SCHEMBL594076
- SCHEMBL27740001
- SCHEMBL29355060
- SYCWERNQGSKYAG-QVRIGTRMSA-N
- EX-A11242
- AKOS040748086
- CS-0011420
- carmoterolum
- RefChem:123748
- DTXCID601528194
- MFCD16621079
- CARMOTEROL [MART.]
- SCHEMBL465645
- GTPL7582
- SCHEMBL27760493
Look up CARMOTEROL in the interactive SynDRA portal →